ACHV20260821C2.5
ACHV Aug 21 2026 2.50 Call (ACHV260821C00002500)
option OPRA

achieve life sciences is a specialty pharmaceutical company committed to advancing cytisine as a smoking cessation aid to overcome the global nicotine addiction epidemic.